| Haylee M Gustafson, MPAS, PA-C | |
|
1517 Orchard Dr Apt 22, Nebraska City, NE 68410-1575 | |
| (308) 440-4655 | |
| Not Available |
| Full Name | Haylee M Gustafson |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 4 Years |
| Location | 1517 Orchard Dr Apt 22, Nebraska City, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225610421 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chi Health St. Mary's | Nebraska city, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Marys Community Hospital | 7113831926 | 16 |
News Archive
It's clear where the black-and-white striped zebrafish got its name, but less obvious at first glance is what zebrafish has to do with biomedical research. Amazingly, it has biological similarities to humans, which are making this small freshwater fish an increasingly popular model organism for studying vertebrate development, genetics, physiology, and mechanisms of disease.
Ampio Pharmaceuticals, Inc., a biopharmaceutical company conducting clinical trials on its three lead drugs (Zertane completed two phase III studies, Ampion-completed proof of concept studies and Optina), licensing distribution of these drugs and engaged in further drug development, today announced that it completed the planned interim review of the first 50% of patients enrolled in the Optina trial for diabetic macular edema.
A new drug combination could offer hope to children with neuroblastoma - one of the deadliest forms of childhood cancer - by boosting the effectiveness of a promising new gene-targeted treatment.
The euroPLX pharma business development platform is preparing to celebrate its 50th partnering conference on 5 and 6 November 2012 in Sorrento, Italy. Currently held three times a year, euroPLX has been held for the first time in 1995 as the first no-lectures, no-presentations business partnering conference of the life science and pharmaceutical industry worldwide.
Patients with advanced non-small cell lung cancer should only receive treatment with the drug erlotinib before receiving standard chemotherapy if their tumor is known to harbor EGFR mutations, researchers report at the 3rd European Lung Cancer Conference in Geneva, Switzerland.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Haylee M Gustafson, MPAS, PA-C 1517 Orchard Dr Apt 22, Nebraska City, NE 68410-1575 Ph: () - | Haylee M Gustafson, MPAS, PA-C 1517 Orchard Dr Apt 22, Nebraska City, NE 68410-1575 Ph: (308) 440-4655 |
News Archive
It's clear where the black-and-white striped zebrafish got its name, but less obvious at first glance is what zebrafish has to do with biomedical research. Amazingly, it has biological similarities to humans, which are making this small freshwater fish an increasingly popular model organism for studying vertebrate development, genetics, physiology, and mechanisms of disease.
Ampio Pharmaceuticals, Inc., a biopharmaceutical company conducting clinical trials on its three lead drugs (Zertane completed two phase III studies, Ampion-completed proof of concept studies and Optina), licensing distribution of these drugs and engaged in further drug development, today announced that it completed the planned interim review of the first 50% of patients enrolled in the Optina trial for diabetic macular edema.
A new drug combination could offer hope to children with neuroblastoma - one of the deadliest forms of childhood cancer - by boosting the effectiveness of a promising new gene-targeted treatment.
The euroPLX pharma business development platform is preparing to celebrate its 50th partnering conference on 5 and 6 November 2012 in Sorrento, Italy. Currently held three times a year, euroPLX has been held for the first time in 1995 as the first no-lectures, no-presentations business partnering conference of the life science and pharmaceutical industry worldwide.
Patients with advanced non-small cell lung cancer should only receive treatment with the drug erlotinib before receiving standard chemotherapy if their tumor is known to harbor EGFR mutations, researchers report at the 3rd European Lung Cancer Conference in Geneva, Switzerland.
› Verified 1 days ago
Jordan Richard Gustafson, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1301 Grundman Blvd, Nebraska City, NE 68410 Phone: 402-873-3321 | |
Brea Smith Proffitt, PAC Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1301 Grundman Blvd Ste A, Nebraska City, NE 68410 Phone: 402-873-4242 | |
Samantha A Barnhart, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1301 Grundman Blvd, Suite A, Nebraska City, NE 68410 Phone: 402-873-4242 Fax: 402-873-4227 | |
Douglas J Langemeier, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1700 14th Ave, Nebraska City, NE 68410 Phone: 402-873-4242 Fax: 402-873-4227 | |
Mr. Michael John Sebek, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1700 14th Ave, Nebraska City, NE 68410 Phone: 402-873-4242 Fax: 402-873-4227 |